The new collaboration combines MD Anderson’s unique understanding of potential drivers of PDAC with Boehringer Ingelheim’s experience in drug discovery and development. Pancreatic cancer accounts for four percent
Based on Thermo Fisher Scientific’s Oncomine Focus Assay, the AOP 50 Assay allows concurrent analysis of DNA and RNA from solid tumors, enabling sequencing of 35 hotspot genes
These detailed "fingerprints" show the surprising complexity of how these receptors activate their binding partners to produce a wide range of signaling actions. The study, which was published
Unlike more traditional therapeutic modalities such as small molecules or antibodies, Neurona is focused on unique compositions of cells that can be precisely targeted, integrated into damaged neural
The study, named PYTHIA, will follow women with advanced breast cancer being treated with anti-hormonal therapy in combination with palbociclib, a cancer therapy belonging to a class of
IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies. Clinical trials are the most
Subject to FDA acceptance, MabVax plans to initiate the Phase I clinical trial early in 2016. The planned Phase I trial will evaluate the safety, tolerability and pharmacokinetics
The EORTC contributed to the trial design and will assist ImmunoCellular Therapeutics in facilitating accrual of patients for this trial in Europe. EORTC Brain Tumor Group chairman and
In a recent meeting members of both boards analyzed preliminary Phase IIa safety and efficacy data from CardioCell’s on-going chronic heart failure (HF) study, "Single-blind, Placebo-controlled, Crossover, Multi-center,
Crispr-Cas9 is a DNA cutting and pasting system and by tweaking the system the scientists claim they can safely and accurately edit human genes for curing inherited or
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.